Capital · venture → company
LVG Seed I & II
Two $10M funds that back UVA ventures right off the lab bench.
$20Macross two funds
2exits
~$75MFund I follow-on
Overview
Fund I invested in 10 companies and produced two exits — TypeZero to Dexcom and 510 Kardiac to Keystone Heart — with about $75M in follow-on capital. Fund II, launched in 2022, is evergreen and deliberately earlier stage.
- Fund I — $10M, 10 companies, about $75M follow-on
- Fund II — $10M, launched 2022, evergreen
- $540,000 invested across 5 UVA ventures this year